<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Presseportal.de - clinical trial</title><link>https://www.presseportal.de/st/clinical%20trial?langid=2</link><description>Presseportal - Deutschlands umfassende Datenbank für Presseinformationen in Text, Bild, Ton und Video - ein Service der dpa-Tochter news aktuell</description><language>de-de</language><copyright>news aktuell GmbH</copyright><image><url>https://www.presseportal.de/images/logos/logo-de-250.jpg</url><title>Presseportal.de - clinical trial</title><link>https://www.presseportal.de/st/clinical%20trial?langid=2</link></image><managingEditor>info@presseportal.de (presseportal.de)</managingEditor><pubDate>Mon, 14 Sep 2026 14:13:05 +0200</pubDate><lastBuildDate>Mon, 14 Sep 2026 08:23:01 +0200</lastBuildDate><category>clinical trial</category><ttl>6</ttl><atom:link href="https://www.presseportal.de/rss/st/clinical+trial.rss2?langid=2" rel="self" type="application/rss+xml" /><item><title>iuvando Health and Immatics collaborate to improve access to clinical trials for patients with metastatic melanoma</title><description>iuvando Health GmbH: Mannheim (ots) - iuvando Health, a leading health tech company specializing in clinical trials matching and physician-led patient navigation support, today announced its collaboration with Immatics, the global leader in precision targeting of PRAME ...</description><link>https://www.presseportal.de/pm/183387/6351164?langid=2</link><pubDate>Mon, 14 Sep 2026 08:23:01 +0200</pubDate><guid>https://www.presseportal.de/pm/183387/6351164?langid=2</guid>
<content:encoded><![CDATA[<b>iuvando Health GmbH</b> [<a href="https://www.presseportal.de/pm/183387/6351164?langid=2">Newsroom</a>]<br/>Mannheim (ots) - iuvando Health, a leading health tech company specializing in clinical trials matching and physician-led patient navigation support, today announced its collaboration with Immatics, the global leader in precision targeting of PRAME ... <a href="https://www.presseportal.de/pm/183387/6351164?langid=2">Lesen Sie hier weiter...</a><br clear="all" /><p><small>Original-Content von: iuvando Health GmbH, übermittelt durch news aktuell</small></p>
]]></content:encoded><category>Gesundheit / Medizin</category><author>info@presseportal.de (presseportal.de)</author><source url="https://www.presseportal.de/pm/183387/6351164?langid=2">iuvando Health GmbH</source></item></channel></rss>